z-logo
open-access-imgOpen Access
SARS ‐CoV‐2, bacterial co‐infections, and AMR : the deadly trio in COVID ‐19?
Author(s) -
Bengoechea Jose A,
Bamford Connor GG
Publication year - 2020
Publication title -
embo molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.923
H-Index - 107
eISSN - 1757-4684
pISSN - 1757-4676
DOI - 10.15252/emmm.202012560
Subject(s) - covid-19 , microbiology and biotechnology , virology , biology , medicine , outbreak , infectious disease (medical specialty) , disease , pathology
Respiratory viral infections are well known to predispose patients to bacterial co‐infections and superinfections. Still, there is limited reference to these in COVID ‐19. Do co‐infections play a significant role during COVID ‐19? What is the impact of antimicrobial resistance?

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom